Literature DB >> 22758393

Recent progress in copolymer-mediated siRNA delivery.

Zong-Wei Wu1, Chih-Te Chien, Chia-Yeh Liu, Jia-Ying Yan, Shu-Yi Lin.   

Abstract

RNAi-mediated gene silencing has great potential for treating various diseases, including cancer, by delivering a specific short interfering RNA (siRNA) to knock down pathogenic mRNAs and suppress protein translation. Although many researchers are dedicated to devising polymer-based vehicles for exogenous in vitro siRNA transfection, few synthetic vehicles are feasible in vivo. Recent studies have presented copolymer-based vectors that are minimally immunogenic and facilitate highly efficient internalizing of exogenous siRNA, compared with homopolymer-based vectors. Cationic segments, organelle-escape units, and degradable fragments are essential to a copolymer-based vehicle for siRNA delivery. The majority of these cationic segments are derived from polyamines, including polylysine, polyarginine, chitosan, polyethylenimines and polyamidoamine dendrimers. Not only do these cationic polyamines protect siRNA, they can also promote disruption of endosomal membranes. Degradable fragments of copolymers must be derived from various polyelectrolytes to release the siRNA once the complexes enter the cytoplasm. This review describes recent progress in copolymer-mediated siRNA delivery, including various building blocks for biocompatible copolymers for efficient in vitro siRNA delivery, and a useful basis for addressing the challenges of in vivo siRNA delivery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22758393     DOI: 10.3109/1061186X.2012.699057

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  13 in total

1.  Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Authors:  Swati Biswas; Pranali P Deshpande; Gemma Navarro; Namita S Dodwadkar; Vladimir P Torchilin
Journal:  Biomaterials       Date:  2012-11-05       Impact factor: 12.479

2.  Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  J Pharmacol Exp Ther       Date:  2019-04-02       Impact factor: 4.030

3.  Nanolayered siRNA dressing for sustained localized knockdown.

Authors:  Steven Castleberry; Mary Wang; Paula T Hammond
Journal:  ACS Nano       Date:  2013-05-17       Impact factor: 15.881

Review 4.  Delivery strategies and potential targets for siRNA in major cancer types.

Authors:  So Jin Lee; Min Ju Kim; Ick Chan Kwon; Thomas M Roberts
Journal:  Adv Drug Deliv Rev       Date:  2016-05-31       Impact factor: 15.470

5.  Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a.

Authors:  Ritu Goyal; Chintan H Kapadia; Jilian R Melamed; Rachel S Riley; Emily S Day
Journal:  Cell Mol Bioeng       Date:  2018-06-06       Impact factor: 2.321

6.  Construction of a tumor cell-targeting non-viral gene delivery vector with polyethylenimine modified with RGD sequence-containing peptide.

Authors:  Hai-Bo Xing; Hong-Ming Pan; Yong Fang; Xiao-Yun Zhou; Qin Pan; DA Li
Journal:  Oncol Lett       Date:  2013-11-29       Impact factor: 2.967

7.  Screening nylon-3 polymers, a new class of cationic amphiphiles, for siRNA delivery.

Authors:  Venkatareddy Nadithe; Runhui Liu; Bryan A Killinger; Sara Movassaghian; Na Hyung Kim; Anna B Moszczynska; Kristyn S Masters; Samuel H Gellman; Olivia M Merkel
Journal:  Mol Pharm       Date:  2014-12-05       Impact factor: 4.939

Review 8.  Molecular Mechanisms and Biological Functions of siRNA.

Authors:  Hassan Dana; Ghanbar Mahmoodi Chalbatani; Habibollah Mahmoodzadeh; Rezvan Karimloo; Omid Rezaiean; Amirreza Moradzadeh; Narges Mehmandoost; Fateme Moazzen; Ali Mazraeh; Vahid Marmari; Mohammad Ebrahimi; Mohammad Menati Rashno; Saeid Jan Abadi; Elahe Gharagouzlo
Journal:  Int J Biomed Sci       Date:  2017-06

Review 9.  Recent developments in nanoparticle-based siRNA delivery for cancer therapy.

Authors:  Jong-Min Lee; Tae-Jong Yoon; Young-Seok Cho
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

10.  Dendrimers for siRNA Delivery.

Authors:  Swati Biswas; Vladimir P Torchilin
Journal:  Pharmaceuticals (Basel)       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.